Sort
51,593 grants matching “hepatitis”
Lipogenesis, lipoprotein flux & CVD risk: role of meal composition & frequency
$604,426Jean-Marc Schwarz · Touro University Of California · R01 · FY2014 · HL
Structure and Replication of Hepatitis Delta Virus
$604,374Institute For Cancer Research · R01 · FY2004 · AI
Integrated approaches to close the loop in type 1 diabetes
$604,353Ananda Basu · University Of Virginia · R01 · FY2020 · DK
Dissecting the Acid Ceramidase Pathway in Hepatic Fibrogenesis
$604,327Jennifer Y. Chen · University Of California, San Francisco · R01 · FY2025 · DK
OVERCOMING THE PROTECTIVE BARRIERS OF BREAST CANCER IN BONE MARROW WITH TARGETED PRODRUG NANOTHERAPY
$604,272Gregory M Lanza · Washington University · R01 · FY2019 · CA
New Approaches To Active Immunoprophylaxis
$604,265Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Clinical Core
$604,143Cornelia L Dekker · Stanford University · U19 · FY2018 · AI
HIV RISK BEHAVIORS AMONG URBAN NOMAD DRUG INJECTORS
$604,122National Development &Res Institutes · R01 · FY2002 · DA
Passive-Active Immunization Strategies Against Pediatric AIDS
$604,079Marta L Marthas · University Of California At Davis · R01 · FY2007 · AI
Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation
$604,063Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2025 · CA
Interleukin 33 Regulation for Cancer Prevention in Chronic Inflammation
$604,063Shadmehr Demehri · Massachusetts General Hospital · R01 · FY2024 · CA
Neurobehavioral Effects of HIV & Host Genetics in China
$603,862Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2009 · MH
HIV-Infected IDU Living with HCV Coinfection
$603,759Columbia University Health Sciences · R01 · FY2003 · DA
Investigation of management and disease manifestations of viral hepatitis
$603,747Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Development of a novel drug candidate that inhibits hepatitis B virus covalently
$603,728Haitao Guo · Drexel University · R01 · FY2013 · AI
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$603,715Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Low Dose Interleukin-2 for Regulatory T cell Modulation and the Treatment of CrohnâÂÂs Disease
$603,706Scott B Snapper · Boston Children'S Hospital · R01 · FY2020 · DK
Defining the role of PLA2G12B on apoB-containing lipoprotein assembly, plasma levels, metabolism and cardiovascular disease risk
$603,632Steven A Farber · Johns Hopkins University · R01 · FY2025 · DK
Risk of Influenza Infection In A Vaccinated Obese Population
$603,592Melinda A. Beck · Univ Of North Carolina Chapel Hill · R01 · FY2010 · AI
Racial Difference in Hepatitis C Virus-Host Interactions and Response
$603,548Tony N. Marion · University Of Tennessee Health Sci Ctr · U19 · FY2007 · AI
Atheroregression via Enhanced Reverse Choleserol Transport
$603,540Henry J. Pownall · Baylor College Of Medicine · R01 · FY2011 · HL
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection
$603,522Norah A. Terrault · University Of California, San Francisco · U01 · FY2011 · DK
Funct character of GABA_B receptor modulators, drug metabolism, pharmacokinetics
$603,509Patrick Robert Griffin · University Of California, San Diego · U19 · FY2014 · DA
Inflammatory response to sleep apnea in obese subjects
$603,495Julio Alonso Chirinos Medina · University Of Pennsylvania · R01 · FY2010 · HL
Racial Difference in HCV-Host Interactions and Response
$603,478Tony N. Marion · University Of Tennessee Health Sci Ctr · U19 · FY2006 · AI